+1 (704) 266-3234

Global Sepsis Diagnostics Market Size, Status And Forecast 2021-2027

Published on: Jul 2021 | From USD $2900 | Published By: QY RESEARCH | Number Of Pages: 120

Sepsis is a three-staged syndrome; it starts with systemic infections leading to severe sepsis and ultimately causing sepsis shock, which is regarded as a medical emergency. Population with weak immune system, which include children, older adults, and people with chronic diseases such as cancer, AIDS, diabetes, are prone to sepsis.
Sepsis occurs mainly due to bacterial, viral, and fungal infections. Gram-negative bacilli such as E. coli, P. aeruginosa, E. corrodens, and Haemophilus influenzae (which occurs mainly in neonates) are the main agents that cause infection, leading to sepsis. Other bacteria which causes sepsis are S. aureus, Streptococcus species, Enterococcus species, and Neisseria species.
North America is expected to command the largest share of the market in 2018, due to the growing prevalence of sepsis, fast adoption of high-end sepsis diagnostics devices, and rising government support for sepsis-related research.

Market Analysis and Insights: Global Sepsis Diagnostics Market
The global Sepsis Diagnostics market size is projected to reach US$ 528.8 million by 2027, from US$ 360.5 million in 2020, at a CAGR of 5.2% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Sepsis Diagnostics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Sepsis Diagnostics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Sepsis Diagnostics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Sepsis Diagnostics market.

Global Sepsis Diagnostics Scope and Market Size
Sepsis Diagnostics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Sepsis Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Microbiology
Molecular Diagnostics
Immunoassays
Flow Cytometry
Microfluidics
Biomarkers

Segment by Application
Hospitals
Pathology & Reference Laboratories

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Biomerieux
T2 Biosystems
Luminex
Becton, Dickinson
Roche
Danaher
Thermo Fisher
Bruker
Abbott
Immunexpress
Response Biomedical
Axis-Shield Diagnostics
Cytosorbents
Mitsubishi Chemical
EKF Diagnostics

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sepsis Diagnostics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Microbiology
1.2.3 Molecular Diagnostics
1.2.4 Immunoassays
1.2.5 Flow Cytometry
1.2.6 Microfluidics
1.2.7 Biomarkers
1.3 Market by Application
1.3.1 Global Sepsis Diagnostics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Pathology & Reference Laboratories
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Sepsis Diagnostics Market Perspective (2016-2027)
2.2 Sepsis Diagnostics Growth Trends by Regions
2.2.1 Sepsis Diagnostics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Sepsis Diagnostics Historic Market Share by Regions (2016-2021)
2.2.3 Sepsis Diagnostics Forecasted Market Size by Regions (2022-2027)
2.3 Sepsis Diagnostics Industry Dynamic
2.3.1 Sepsis Diagnostics Market Trends
2.3.2 Sepsis Diagnostics Market Drivers
2.3.3 Sepsis Diagnostics Market Challenges
2.3.4 Sepsis Diagnostics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Sepsis Diagnostics Players by Revenue
3.1.1 Global Top Sepsis Diagnostics Players by Revenue (2016-2021)
3.1.2 Global Sepsis Diagnostics Revenue Market Share by Players (2016-2021)
3.2 Global Sepsis Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Sepsis Diagnostics Revenue
3.4 Global Sepsis Diagnostics Market Concentration Ratio
3.4.1 Global Sepsis Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sepsis Diagnostics Revenue in 2020
3.5 Sepsis Diagnostics Key Players Head office and Area Served
3.6 Key Players Sepsis Diagnostics Product Solution and Service
3.7 Date of Enter into Sepsis Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Sepsis Diagnostics Breakdown Data by Type
4.1 Global Sepsis Diagnostics Historic Market Size by Type (2016-2021)
4.2 Global Sepsis Diagnostics Forecasted Market Size by Type (2022-2027)

5 Sepsis Diagnostics Breakdown Data by Application
5.1 Global Sepsis Diagnostics Historic Market Size by Application (2016-2021)
5.2 Global Sepsis Diagnostics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Sepsis Diagnostics Market Size (2016-2027)
6.2 North America Sepsis Diagnostics Market Size by Type
6.2.1 North America Sepsis Diagnostics Market Size by Type (2016-2021)
6.2.2 North America Sepsis Diagnostics Market Size by Type (2022-2027)
6.2.3 North America Sepsis Diagnostics Market Size by Type (2016-2027)
6.3 North America Sepsis Diagnostics Market Size by Application
6.3.1 North America Sepsis Diagnostics Market Size by Application (2016-2021)
6.3.2 North America Sepsis Diagnostics Market Size by Application (2022-2027)
6.3.3 North America Sepsis Diagnostics Market Size by Application (2016-2027)
6.4 North America Sepsis Diagnostics Market Size by Country
6.4.1 North America Sepsis Diagnostics Market Size by Country (2016-2021)
6.4.2 North America Sepsis Diagnostics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Sepsis Diagnostics Market Size (2016-2027)
7.2 Europe Sepsis Diagnostics Market Size by Type
7.2.1 Europe Sepsis Diagnostics Market Size by Type (2016-2021)
7.2.2 Europe Sepsis Diagnostics Market Size by Type (2022-2027)
7.2.3 Europe Sepsis Diagnostics Market Size by Type (2016-2027)
7.3 Europe Sepsis Diagnostics Market Size by Application
7.3.1 Europe Sepsis Diagnostics Market Size by Application (2016-2021)
7.3.2 Europe Sepsis Diagnostics Market Size by Application (2022-2027)
7.3.3 Europe Sepsis Diagnostics Market Size by Application (2016-2027)
7.4 Europe Sepsis Diagnostics Market Size by Country
7.4.1 Europe Sepsis Diagnostics Market Size by Country (2016-2021)
7.4.2 Europe Sepsis Diagnostics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Sepsis Diagnostics Market Size (2016-2027)
8.2 Asia-Pacific Sepsis Diagnostics Market Size by Type
8.2.1 Asia-Pacific Sepsis Diagnostics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Sepsis Diagnostics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Sepsis Diagnostics Market Size by Type (2016-2027)
8.3 Asia-Pacific Sepsis Diagnostics Market Size by Application
8.3.1 Asia-Pacific Sepsis Diagnostics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Sepsis Diagnostics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Sepsis Diagnostics Market Size by Application (2016-2027)
8.4 Asia-Pacific Sepsis Diagnostics Market Size by Region
8.4.1 Asia-Pacific Sepsis Diagnostics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Sepsis Diagnostics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Sepsis Diagnostics Market Size (2016-2027)
9.2 Latin America Sepsis Diagnostics Market Size by Type
9.2.1 Latin America Sepsis Diagnostics Market Size by Type (2016-2021)
9.2.2 Latin America Sepsis Diagnostics Market Size by Type (2022-2027)
9.2.3 Latin America Sepsis Diagnostics Market Size by Type (2016-2027)
9.3 Latin America Sepsis Diagnostics Market Size by Application
9.3.1 Latin America Sepsis Diagnostics Market Size by Application (2016-2021)
9.3.2 Latin America Sepsis Diagnostics Market Size by Application (2022-2027)
9.3.3 Latin America Sepsis Diagnostics Market Size by Application (2016-2027)
9.4 Latin America Sepsis Diagnostics Market Size by Country
9.4.1 Latin America Sepsis Diagnostics Market Size by Country (2016-2021)
9.4.2 Latin America Sepsis Diagnostics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Sepsis Diagnostics Market Size (2016-2027)
10.2 Middle East & Africa Sepsis Diagnostics Market Size by Type
10.2.1 Middle East & Africa Sepsis Diagnostics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Sepsis Diagnostics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Sepsis Diagnostics Market Size by Type (2016-2027)
10.3 Middle East & Africa Sepsis Diagnostics Market Size by Application
10.3.1 Middle East & Africa Sepsis Diagnostics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Sepsis Diagnostics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Sepsis Diagnostics Market Size by Application (2016-2027)
10.4 Middle East & Africa Sepsis Diagnostics Market Size by Country
10.4.1 Middle East & Africa Sepsis Diagnostics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Sepsis Diagnostics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Biomerieux
11.1.1 Biomerieux Company Details
11.1.2 Biomerieux Business Overview
11.1.3 Biomerieux Sepsis Diagnostics Introduction
11.1.4 Biomerieux Revenue in Sepsis Diagnostics Business (2016-2021)
11.1.5 Biomerieux Recent Development
11.2 T2 Biosystems
11.2.1 T2 Biosystems Company Details
11.2.2 T2 Biosystems Business Overview
11.2.3 T2 Biosystems Sepsis Diagnostics Introduction
11.2.4 T2 Biosystems Revenue in Sepsis Diagnostics Business (2016-2021)
11.2.5 T2 Biosystems Recent Development
11.3 Luminex
11.3.1 Luminex Company Details
11.3.2 Luminex Business Overview
11.3.3 Luminex Sepsis Diagnostics Introduction
11.3.4 Luminex Revenue in Sepsis Diagnostics Business (2016-2021)
11.3.5 Luminex Recent Development
11.4 Becton, Dickinson
11.4.1 Becton, Dickinson Company Details
11.4.2 Becton, Dickinson Business Overview
11.4.3 Becton, Dickinson Sepsis Diagnostics Introduction
11.4.4 Becton, Dickinson Revenue in Sepsis Diagnostics Business (2016-2021)
11.4.5 Becton, Dickinson Recent Development
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Sepsis Diagnostics Introduction
11.5.4 Roche Revenue in Sepsis Diagnostics Business (2016-2021)
11.5.5 Roche Recent Development
11.6 Danaher
11.6.1 Danaher Company Details
11.6.2 Danaher Business Overview
11.6.3 Danaher Sepsis Diagnostics Introduction
11.6.4 Danaher Revenue in Sepsis Diagnostics Business (2016-2021)
11.6.5 Danaher Recent Development
11.7 Thermo Fisher
11.7.1 Thermo Fisher Company Details
11.7.2 Thermo Fisher Business Overview
11.7.3 Thermo Fisher Sepsis Diagnostics Introduction
11.7.4 Thermo Fisher Revenue in Sepsis Diagnostics Business (2016-2021)
11.7.5 Thermo Fisher Recent Development
11.8 Bruker
11.8.1 Bruker Company Details
11.8.2 Bruker Business Overview
11.8.3 Bruker Sepsis Diagnostics Introduction
11.8.4 Bruker Revenue in Sepsis Diagnostics Business (2016-2021)
11.8.5 Bruker Recent Development
11.9 Abbott
11.9.1 Abbott Company Details
11.9.2 Abbott Business Overview
11.9.3 Abbott Sepsis Diagnostics Introduction
11.9.4 Abbott Revenue in Sepsis Diagnostics Business (2016-2021)
11.9.5 Abbott Recent Development
11.10 Immunexpress
11.10.1 Immunexpress Company Details
11.10.2 Immunexpress Business Overview
11.10.3 Immunexpress Sepsis Diagnostics Introduction
11.10.4 Immunexpress Revenue in Sepsis Diagnostics Business (2016-2021)
11.10.5 Immunexpress Recent Development
11.11 Response Biomedical
11.11.1 Response Biomedical Company Details
11.11.2 Response Biomedical Business Overview
11.11.3 Response Biomedical Sepsis Diagnostics Introduction
11.11.4 Response Biomedical Revenue in Sepsis Diagnostics Business (2016-2021)
11.11.5 Response Biomedical Recent Development
11.12 Axis-Shield Diagnostics
11.12.1 Axis-Shield Diagnostics Company Details
11.12.2 Axis-Shield Diagnostics Business Overview
11.12.3 Axis-Shield Diagnostics Sepsis Diagnostics Introduction
11.12.4 Axis-Shield Diagnostics Revenue in Sepsis Diagnostics Business (2016-2021)
11.12.5 Axis-Shield Diagnostics Recent Development
11.13 Cytosorbents
11.13.1 Cytosorbents Company Details
11.13.2 Cytosorbents Business Overview
11.13.3 Cytosorbents Sepsis Diagnostics Introduction
11.13.4 Cytosorbents Revenue in Sepsis Diagnostics Business (2016-2021)
11.13.5 Cytosorbents Recent Development
11.14 Mitsubishi Chemical
11.14.1 Mitsubishi Chemical Company Details
11.14.2 Mitsubishi Chemical Business Overview
11.14.3 Mitsubishi Chemical Sepsis Diagnostics Introduction
11.14.4 Mitsubishi Chemical Revenue in Sepsis Diagnostics Business (2016-2021)
11.14.5 Mitsubishi Chemical Recent Development
11.15 EKF Diagnostics
11.15.1 EKF Diagnostics Company Details
11.15.2 EKF Diagnostics Business Overview
11.15.3 EKF Diagnostics Sepsis Diagnostics Introduction
11.15.4 EKF Diagnostics Revenue in Sepsis Diagnostics Business (2016-2021)
11.15.5 EKF Diagnostics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Sepsis Diagnostics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Microbiology
Table 3. Key Players of Molecular Diagnostics
Table 4. Key Players of Immunoassays
Table 5. Key Players of Flow Cytometry
Table 6. Key Players of Microfluidics
Table 7. Key Players of Biomarkers
Table 8. Global Sepsis Diagnostics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Sepsis Diagnostics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Sepsis Diagnostics Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Sepsis Diagnostics Market Share by Regions (2016-2021)
Table 12. Global Sepsis Diagnostics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Sepsis Diagnostics Market Share by Regions (2022-2027)
Table 14. Sepsis Diagnostics Market Trends
Table 15. Sepsis Diagnostics Market Drivers
Table 16. Sepsis Diagnostics Market Challenges
Table 17. Sepsis Diagnostics Market Restraints
Table 18. Global Sepsis Diagnostics Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Sepsis Diagnostics Market Share by Players (2016-2021)
Table 20. Global Top Sepsis Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sepsis Diagnostics as of 2020)
Table 21. Ranking of Global Top Sepsis Diagnostics Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Sepsis Diagnostics Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Sepsis Diagnostics Product Solution and Service
Table 25. Date of Enter into Sepsis Diagnostics Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Sepsis Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Sepsis Diagnostics Revenue Market Share by Type (2016-2021)
Table 29. Global Sepsis Diagnostics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Sepsis Diagnostics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Sepsis Diagnostics Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Sepsis Diagnostics Revenue Market Share by Application (2016-2021)
Table 33. Global Sepsis Diagnostics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Sepsis Diagnostics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Sepsis Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Sepsis Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Sepsis Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Sepsis Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Sepsis Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Sepsis Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Sepsis Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Sepsis Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Sepsis Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Sepsis Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Sepsis Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Sepsis Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Sepsis Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Sepsis Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Sepsis Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Sepsis Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Sepsis Diagnostics Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Sepsis Diagnostics Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Sepsis Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Sepsis Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Sepsis Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Sepsis Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Sepsis Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Sepsis Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Sepsis Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Sepsis Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Sepsis Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Sepsis Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Sepsis Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Sepsis Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 65. Biomerieux Company Details
Table 66. Biomerieux Business Overview
Table 67. Biomerieux Sepsis Diagnostics Product
Table 68. Biomerieux Revenue in Sepsis Diagnostics Business (2016-2021) & (US$ Million)
Table 69. Biomerieux Recent Development
Table 70. T2 Biosystems Company Details
Table 71. T2 Biosystems Business Overview
Table 72. T2 Biosystems Sepsis Diagnostics Product
Table 73. T2 Biosystems Revenue in Sepsis Diagnostics Business (2016-2021) & (US$ Million)
Table 74. T2 Biosystems Recent Development
Table 75. Luminex Company Details
Table 76. Luminex Business Overview
Table 77. Luminex Sepsis Diagnostics Product
Table 78. Luminex Revenue in Sepsis Diagnostics Business (2016-2021) & (US$ Million)
Table 79. Luminex Recent Development
Table 80. Becton, Dickinson Company Details
Table 81. Becton, Dickinson Business Overview
Table 82. Becton, Dickinson Sepsis Diagnostics Product
Table 83. Becton, Dickinson Revenue in Sepsis Diagnostics Business (2016-2021) & (US$ Million)
Table 84. Becton, Dickinson Recent Development
Table 85. Roche Company Details
Table 86. Roche Business Overview
Table 87. Roche Sepsis Diagnostics Product
Table 88. Roche Revenue in Sepsis Diagnostics Business (2016-2021) & (US$ Million)
Table 89. Roche Recent Development
Table 90. Danaher Company Details
Table 91. Danaher Business Overview
Table 92. Danaher Sepsis Diagnostics Product
Table 93. Danaher Revenue in Sepsis Diagnostics Business (2016-2021) & (US$ Million)
Table 94. Danaher Recent Development
Table 95. Thermo Fisher Company Details
Table 96. Thermo Fisher Business Overview
Table 97. Thermo Fisher Sepsis Diagnostics Product
Table 98. Thermo Fisher Revenue in Sepsis Diagnostics Business (2016-2021) & (US$ Million)
Table 99. Thermo Fisher Recent Development
Table 100. Bruker Company Details
Table 101. Bruker Business Overview
Table 102. Bruker Revenue in Sepsis Diagnostics Business (2016-2021) & (US$ Million)
Table 103. Bruker Recent Development
Table 104. Abbott Company Details
Table 105. Abbott Business Overview
Table 106. Abbott Sepsis Diagnostics Product
Table 107. Abbott Revenue in Sepsis Diagnostics Business (2016-2021) & (US$ Million)
Table 108. Abbott Recent Development
Table 109. Immunexpress Company Details
Table 110. Immunexpress Business Overview
Table 111. Immunexpress Sepsis Diagnostics Product
Table 112. Immunexpress Revenue in Sepsis Diagnostics Business (2016-2021) & (US$ Million)
Table 113. Immunexpress Recent Development
Table 114. Response Biomedical Company Details
Table 115. Response Biomedical Business Overview
Table 116. Response Biomedical Sepsis Diagnostics Product
Table 117. Response Biomedical Revenue in Sepsis Diagnostics Business (2016-2021) & (US$ Million)
Table 118. Response Biomedical Recent Development
Table 119. Axis-Shield Diagnostics Company Details
Table 120. Axis-Shield Diagnostics Business Overview
Table 121. Axis-Shield Diagnostics Sepsis Diagnostics Product
Table 122. Axis-Shield Diagnostics Revenue in Sepsis Diagnostics Business (2016-2021) & (US$ Million)
Table 123. Axis-Shield Diagnostics Recent Development
Table 124. Cytosorbents Company Details
Table 125. Cytosorbents Business Overview
Table 126. Cytosorbents Sepsis Diagnostics Product
Table 127. Cytosorbents Revenue in Sepsis Diagnostics Business (2016-2021) & (US$ Million)
Table 128. Cytosorbents Recent Development
Table 129. Mitsubishi Chemical Company Details
Table 130. Mitsubishi Chemical Business Overview
Table 131. Mitsubishi Chemical Sepsis Diagnostics Product
Table 132. Mitsubishi Chemical Revenue in Sepsis Diagnostics Business (2016-2021) & (US$ Million)
Table 133. Mitsubishi Chemical Recent Development
Table 134. EKF Diagnostics Company Details
Table 135. EKF Diagnostics Business Overview
Table 136. EKF Diagnostics Sepsis Diagnostics Product
Table 137. EKF Diagnostics Revenue in Sepsis Diagnostics Business (2016-2021) & (US$ Million)
Table 138. EKF Diagnostics Recent Development
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Sepsis Diagnostics Market Share by Type: 2020 VS 2027
Figure 2. Microbiology Features
Figure 3. Molecular Diagnostics Features
Figure 4. Immunoassays Features
Figure 5. Flow Cytometry Features
Figure 6. Microfluidics Features
Figure 7. Biomarkers Features
Figure 8. Global Sepsis Diagnostics Market Share by Application: 2020 VS 2027
Figure 9. Hospitals Case Studies
Figure 10. Pathology & Reference Laboratories Case Studies
Figure 11. Sepsis Diagnostics Report Years Considered
Figure 12. Global Sepsis Diagnostics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Sepsis Diagnostics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Sepsis Diagnostics Market Share by Regions: 2020 VS 2027
Figure 15. Global Sepsis Diagnostics Market Share by Regions (2022-2027)
Figure 16. Global Sepsis Diagnostics Market Share by Players in 2020
Figure 17. Global Top Sepsis Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sepsis Diagnostics as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Sepsis Diagnostics Revenue in 2020
Figure 19. Global Sepsis Diagnostics Revenue Market Share by Type (2016-2021)
Figure 20. Global Sepsis Diagnostics Revenue Market Share by Type (2022-2027)
Figure 21. North America Sepsis Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Sepsis Diagnostics Market Share by Type (2016-2027)
Figure 23. North America Sepsis Diagnostics Market Share by Application (2016-2027)
Figure 24. North America Sepsis Diagnostics Market Share by Country (2016-2027)
Figure 25. United States Sepsis Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Sepsis Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Sepsis Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Sepsis Diagnostics Market Share by Type (2016-2027)
Figure 29. Europe Sepsis Diagnostics Market Share by Application (2016-2027)
Figure 30. Europe Sepsis Diagnostics Market Share by Country (2016-2027)
Figure 31. Germany Sepsis Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Sepsis Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Sepsis Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Sepsis Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Sepsis Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Sepsis Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Sepsis Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Sepsis Diagnostics Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Sepsis Diagnostics Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Sepsis Diagnostics Market Share by Region (2016-2027)
Figure 41. China Sepsis Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Sepsis Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Sepsis Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Sepsis Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Sepsis Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Sepsis Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Sepsis Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Sepsis Diagnostics Market Share by Type (2016-2027)
Figure 49. Latin America Sepsis Diagnostics Market Share by Application (2016-2027)
Figure 50. Latin America Sepsis Diagnostics Market Share by Country (2016-2027)
Figure 51. Mexico Sepsis Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Sepsis Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Sepsis Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Sepsis Diagnostics Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Sepsis Diagnostics Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Sepsis Diagnostics Market Share by Country (2016-2027)
Figure 57. Turkey Sepsis Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Sepsis Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Sepsis Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Biomerieux Revenue Growth Rate in Sepsis Diagnostics Business (2016-2021)
Figure 61. T2 Biosystems Revenue Growth Rate in Sepsis Diagnostics Business (2016-2021)
Figure 62. Luminex Revenue Growth Rate in Sepsis Diagnostics Business (2016-2021)
Figure 63. Becton, Dickinson Revenue Growth Rate in Sepsis Diagnostics Business (2016-2021)
Figure 64. Roche Revenue Growth Rate in Sepsis Diagnostics Business (2016-2021)
Figure 65. Danaher Revenue Growth Rate in Sepsis Diagnostics Business (2016-2021)
Figure 66. Thermo Fisher Revenue Growth Rate in Sepsis Diagnostics Business (2016-2021)
Figure 67. Bruker Revenue Growth Rate in Sepsis Diagnostics Business (2016-2021)
Figure 68. Abbott Revenue Growth Rate in Sepsis Diagnostics Business (2016-2021)
Figure 69. Immunexpress Revenue Growth Rate in Sepsis Diagnostics Business (2016-2021)
Figure 70. Response Biomedical Revenue Growth Rate in Sepsis Diagnostics Business (2016-2021)
Figure 71. Axis-Shield Diagnostics Revenue Growth Rate in Sepsis Diagnostics Business (2016-2021)
Figure 72. Cytosorbents Revenue Growth Rate in Sepsis Diagnostics Business (2016-2021)
Figure 73. Mitsubishi Chemical Revenue Growth Rate in Sepsis Diagnostics Business (2016-2021)
Figure 74. EKF Diagnostics Revenue Growth Rate in Sepsis Diagnostics Business (2016-2021)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Please Choose License Type

USD $2900
USD $3900
USD $4900
COVID-19
Offer

WHY US?

  • Why Us In-depth database
    Our Report’s database covers almost all topics of all regions over the Globe..
  • Why Us Recognised publishing sources
    Tie ups with top publishers around the globe.
  • Why Us Customer Support
    Complete pre and post sales support.
  • Why Us Safe & Secure
    Complete secure payment process.